Clinical trial
An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin
NCT01128712 is registered in ClinicalTrials.gov with Northeast Regional Epilepsy Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin
- Lead sponsor
- Northeast Regional Epilepsy Group
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2010
- Completion date
- July 31, 2014
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.